Avaliação do potencial antigênico da candidata a vacina antimalárica GMZ2. 6c e seus componentes, Proteína 3 da Superfície do Merozoíto (MSP-3), Proteína Rica …
BO Baptista - 2017 - arca.fiocruz.br
A malária é causada por protozoários do gênero Plasmodium. Estima-se que ocorram 212
milhões de casos e 300 mil mortes decorrentes de malária anualmente, principalmente …
milhões de casos e 300 mil mortes decorrentes de malária anualmente, principalmente …
Progress in the development of a malaria vaccine
APS Freitas - 2016 - estudogeral.uc.pt
Malaria is a public health problem and in the year of 2015 were estimated 214 million cases
worldwide. Malaria is caused by a parasite of the Genus Plasmodium sp. and it is …
worldwide. Malaria is caused by a parasite of the Genus Plasmodium sp. and it is …
Mitochondrial Heteroplasmy Contributes to the Dynamic Atovaquone Resistance Response in Plasmodium falciparum
SV Siegel - 2016 - search.proquest.com
Of the considerable challenges researchers face in the control and elimination of malaria,
the development of antimalarial drug resistance in parasite populations remains a significant …
the development of antimalarial drug resistance in parasite populations remains a significant …
Développement clinique d'un vaccin antipaludique de stade sanguin et diversité antigénique de Plasmodium Falciparum à Bandiagara, Mali
MA Théra - 2015 - theses.hal.science
Un vaccin efficace contre le paludisme constitue un outil puissant dans la lutte contre ce
fléau. L'antigène 1 de la membrane apicale du mérozoïte, AMA1 est une protéine …
fléau. L'antigène 1 de la membrane apicale du mérozoïte, AMA1 est une protéine …
Genome-wide Analysis and Diversity of Plasmodium Falciparum in Lagos and Ekiti States, South-West Nigeria
KM Oyebola - 2015 - search.proquest.com
Malaria is a disease that causes more than half a million deaths each year. Compounding
the disease burden is high level of genetic variability of the causative parasites which are …
the disease burden is high level of genetic variability of the causative parasites which are …
Plasmodium falciparum RTS,S vaccines and future development
T Egwang - 2014 - Taylor & Francis
RTS, S contains Plasmodium falciparum circumsporozoite protein (CSP) fused to hepatitis B
surface antigen and expressed as virus-like particles. CSP is a protein found on the surface …
surface antigen and expressed as virus-like particles. CSP is a protein found on the surface …
[PDF][PDF] マラリア動物モデルを用いた5-アミノレブリン酸および二価鉄イオンの経口による併用投与の治療と防御効果の評価
鈴木 - repository.dl.itc.u-tokyo.ac.jp
博士論文 マラリア動物モデルを用いた 5-アミノレブリン酸および二価鉄 イオンの経口による併
Page 1 博士論文 マラリア動物モデルを用いた 5-アミノレブリン酸および二価鉄 イオンの経口による …
Page 1 博士論文 マラリア動物モデルを用いた 5-アミノレブリン酸および二価鉄 イオンの経口による …
新規アジュバントを添加した次世代SE36 マラリアワクチンの開発: 旅行者用ワクチンへのアプローチ
東岸任弘, 石井健, 堀井俊宏 - YAKUGAKU ZASSHI, 2013 - jstage.jst.go.jp
抄録 The SE36 antigen, derived from serine repeat antigen 5 (SERA5) of Plasmodium
falciparum, is a promising blood stage malaria vaccine candidate. Previous clinical trials …
falciparum, is a promising blood stage malaria vaccine candidate. Previous clinical trials …
[引用][C] Artículo de revisión Avances en el desarrollo de una vacuna contra la malaria por Plasmodium falciparum: una revisión de literatura
AMG Rodríguez, JS Molina, FD Ricardo, S Jiménez…